Do Lockdowns Bring about Additional Mortality Benefits or Costs? Evidence based on Death Records from 300 Million Chinese People

Jinlei Qi(National Center for Chronic and Noncommunicable Disease Control and Prevention), Maigeng Zhou(National Center for Chronic and Noncommunicable Disease Control and Prevention), Peiyu Xie(Peking University), Guojun He(Hong Kong University of Science and Technology), Yuhang Pan(George Institute for Global Health), Jiangmei Liu(Chinese Center For Disease Control and Prevention), Zhaoguang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiang Zhang(Shaanxi History Museum), Dandan Zhang(Dongguan University of Technology), Shuocen Liu(Peking University), Peng Yin(National Center for Chronic and Noncommunicable Disease Control and Prevention), George F. Gao(Chinese Academy of Sciences)
medRxiv
September 1, 2020
10.1101/2020.08.28.20183699
Cited by 20

Related Papers

A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.8k
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
|The Lancet|2015|6.5k
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k